Insight on Biotech in United States

Published within

« | 1 | » »|

Type Product title / description Pub Price
Report
Report

Pharmaceutical Company Outlook to 2014

Assess the outlook for the PharmaVitae universe of leading Rx pharma companies to 2014, in terms of both sales and operating performance. Analyze the industry by peer set, balance of launches / expiries, and therapeutic and molecule type focus.

Published By Datamonitor
23 Dec 2009 $7600
Buy
Report
Report

Hemophilia Pipeline Overview – Once-a-week prophylaxis may soon become a reality

Datamonitor provides an overview of and profiles key hemophilia A and B pipeline products launching in the near future in the US and five major EU markets (France, Germany, Italy, Spain, and the UK).

Published By Datamonitor
12 Nov 2012 $3800
Buy
Report
Report

The Orphan Drug Market Outlook to 2017

This report provides an analysis of the orphan drug market. It comprises brands that have gained US FDA orphan drug approval, as well as Phase III pipeline candidates that have gained an orphan drug designation from the FDA.

Published By Datamonitor
08 Jan 2013 $3500
Buy

« | 1 | » »|

No help is available.